Nasal Antisepsis for C. Auris Prevention

计划入组 120 人 · 首次发布于 2024 年 2 月 28 日

Evaluation of Rapid Diagnostic Device for the Detection of Candida Auris

计划入组 554 人 · 首次发布于 2025 年 11 月 28 日

Molecular Characterization of Candida Auris

计划入组 384 人 · 首次发布于 2019 年 10 月 10 日

Auris-Sedina

AM-102

C 135LS/C 144LS

AURIS MEDICAL, INC.

United States

Auris Medical AG

Switzerland

AURIS HEALTH, INC.

United States

Ondine Biomedical's Steriwave Technology Shows 99.9% Efficacy Against Drug-Resistant C. auris as European Cases Surge 67%

SCYNEXIS Presents Promising Data on SCY-247 Against Drug-Resistant Fungal Infections at TIMM-12 Congress

Candida auris Candidemia: SOFA Score Predicts Mortality as Echinocandins Remain Effective First-Line Therapy